# vasopharm

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/vasopharm

- Industry: Pharmaceuticals
- Headquarters: Wurzburg, Germany
- Website: www.vasopharm.com
- Total disclosed funding: $46M
- Latest round: Series G (Dec 21, 2015)
- Investors on record: 9

## About

vasopharm GmbH is a biopharmaceutical company focused on developing innovative solutions to address unmet medical needs in critical care and neurology, enhancing treatment outcomes through targeted pharmacological interventions.Established in 1998 and headquartered in Wurzburg, Germany, vasopharm GmbH specializes in biopharmaceutical development. The company has pursued multiple funding rounds, with the most recent being a GROWTH round in June 2019, raising USD 9.5 mn from investors including Bayern Kapital and Creathor Ventures. The current CEO is Christian Wandersee.vasopharm GmbH offers advanced pharmaceutical solutions targeting critical conditions in neurology and critical care. Their product line is designed for effective management of chronic and acute illnesses, primarily serving healthcare providers and specialty clinics across major European markets such as Germany, France, and the United Kingdom.The revenue model of vasopharm GmbH relies on B2B transactions with healthcare institutions, utilizing a subscription model for product access and ongoing support. Pricing structures reflect the therapeutic value provided to improve patient outcomes, aiming to build long-term client relationships within the healthcare sector.Following the GROWTH funding round completed on June 27, 2019, which raised USD 9.5 mn, vasopharm GmbH plans to leverage this capital for the development of new products aimed at expanding its therapeutic offerings. The company is targeting expansion into additional European markets and may look to initiate operations in new geographic regions by 2022, aligning with their strategy to enhance their product lineup and market reach.

## Funding rounds

- Series G, Dec 21, 2015, $22M — HeidelbergCapital, Bayern Kapital, Entrepreneurs Fund Management, Hanseatic Asset Management GmbH, Fort Rock Capital
- Series F, Jun 7, 2013, $6.7M — HeidelbergCapital, Bayern Kapital, Entrepreneurs Fund Management, Hanseatic Asset Management GmbH
- Series D, Apr 23, 2009, $6M — EMBL Ventures, KfW Banking Group, HeidelbergCapital, Entrepreneurs Fund Management
- Series B, Jan 30, 2006, $11M — 3i, EMBL Ventures, KfW Banking Group, Bayern Kapital, Entrepreneurs Fund Management, Future Capital(duplicated)

## Investors

- 3i (https://capitalatlas.ai/funds/3i) — Series B
- EMBL Ventures (https://capitalatlas.ai/funds/embl-ventures) — Series B, Series D
- KfW Banking Group — Series B, Series D
- Bayern Kapital (https://capitalatlas.ai/funds/bayern-kapital) — Series B, Series F, Series G
- Entrepreneurs Fund Management (https://capitalatlas.ai/funds/entrepreneurs-fund-management) — Series B, Series D, Series F, Series G
- Future Capital(duplicated) — Series B
- HeidelbergCapital (https://capitalatlas.ai/funds/heidelbergcapital) — Series D, Series F, Series G
- Hanseatic Asset Management GmbH — Series F, Series G
- Fort Rock Capital (https://capitalatlas.ai/funds/fort-rock-capital) — Series G